Possible neuromarker for 'juvenile-onset' Batten disease

Researchers find that an easy-to-measure brain process may be a target or biomarker in measuring treatment outcomes in clinical trials in Batten disease.

Researchers find that an easy-to-measure brain process may be a target or biomarker in measuring treatment outcomes in clinical trials in Batten disease.

Read more https://www.sciencedaily.com/releases/2024/01/240108125743.htm